Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Safety、Immunogenicity”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT01949857
What this trial is testing

The Immunogenicity and Safety of Inactivated and Live Attenuated Hepatitis A Vaccines

Who this might be right for
Hepatitis A
Institute of Medical Biology, Chinese Academy of Medical Sciences 35,000
Testing effectiveness (Phase 2)Study completedNCT02474901
What this trial is testing

Shedding, Immunogenicity and Safety of Quadrivalent Live Intranasal Influenza Vaccine (QLAIV) in HIV-infected Children and Young Adults

Who this might be right for
Human Immunodeficiency Virus (HIV)
University of Colorado, Denver 101
Large-scale testing (Phase 3)Study completedNCT00637195
What this trial is testing

Immunogenicity and Safety of a Commercially Available Vaccine Co-administered With GSK HPV Vaccine (580299)

Who this might be right for
Infections, PapillomavirusPapillomavirus Vaccines
GlaxoSmithKline 152
Large-scale testing (Phase 3)Study completedNCT00380367
What this trial is testing

Safety, Tolerability and Immunogenicity of HPV (Human Papilloma Virus) Vaccine in Healthy Females 9 to 15 Years of Age in India (V501-029)

Who this might be right for
Papillomavirus Infections
Merck Sharp & Dohme LLC 110
Not applicableStudy completedNCT05850507
What this trial is testing

Omicron BA.4/5-Delta Strain Recombinant Novel Coronavirus Protein Vaccine (CHO Cells)

Who this might be right for
Coronavirus
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. 450
Early research (Phase 1)Not Yet RecruitingNCT06500507
What this trial is testing

QLS4131 in Patients With Recurrent or Refractory Multiple Myeloma

Who this might be right for
Relapsed or Refractory Multiple Myeloma
Qilu Pharmaceutical Co., Ltd. 90
Early research (Phase 1)Study completedNCT00076037
What this trial is testing

Safety of and Immune Response to a New HIV Vaccine: HIV CTL MEP

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 96
Large-scale testing (Phase 3)Active Not RecruitingNCT07275645
What this trial is testing

A Clinical Trial of Rabies Vaccine（Human Diploid Cell）for Human Use,Freeze-dried in a Population Aged 10 to 60 Years

Who this might be right for
Rabies
Ab&B Bio-tech Co., Ltd.JS 3,000
Testing effectiveness (Phase 2)Study completedNCT04983030
What this trial is testing

Safety, Immunogenicity, Efficacy of Ad26.Mos4.HIV, MVA-BN-HIV and PGT121, PGDM1400, and VRC07-523LS in HIV-1-Infected Adults

Who this might be right for
HIVAcquired Immunodeficiency SyndromeImmunologic Deficiency Syndrome, Acquired+2 more
Boris Juelg, MD PhD 28
Large-scale testing (Phase 3)Study completedNCT05875701
What this trial is testing

Phase 3 Study of Novavax Vaccine(s) as Booster Dose After mRNA Vaccines

Who this might be right for
COVID-19
Novavax 147
Not applicableLooking for participantsNCT06676644
What this trial is testing

Estimate the Safety and Effectiveness of Adjuvanted Influenza Vaccine Among Asian Elderly People When Compared to Non-adjuvanted Vaccines

Who this might be right for
Influenza VaccinesElderly
National Taiwan University Hospital 200
Early research (Phase 1)Study completedNCT00532792
What this trial is testing

A/H5N1 Dose Ranging Study With Adjuvant Patch

Who this might be right for
Pandemic Influenza
Intercell USA, Inc. 501
Large-scale testing (Phase 3)Study completedNCT02352584
What this trial is testing

A Multicenter, Double-blind, Parallel Phase III Study

Who this might be right for
Influenza
Green Cross Corporation 1,299
Post-approval studies (Phase 4)Study completedNCT02582047
What this trial is testing

Influenza Vaccine and Pneumococcal Vaccine

Who this might be right for
Influenza, HumanPneumococcal Infections
Korea University Guro Hospital 224
Testing effectiveness (Phase 2)Study completedNCT03527355
What this trial is testing

Safety, Reactogenicity and Immunogenicity of Vi-DT;Typhoid Conjugate Vaccine

Who this might be right for
Typhoid
International Vaccine Institute 285
Large-scale testing (Phase 3)Study completedNCT04278248
What this trial is testing

Immunogenicity and Safety of 23-Valent Pneumococcal Polysaccharide Vaccine in Healthy Volunteers Aged 2 Years and Above

Who this might be right for
Pneumonia, Pneumococcal
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd 1,940
Early research (Phase 1)Looking for participantsNCT07239947
What this trial is testing

BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Moderate to Severe Atopic Dermatitis (AD)

Who this might be right for
Atopic Dermatitis
Bambusa Therapeutics 99
Early research (Phase 1)Study completedNCT00000749
What this trial is testing

A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of 200 Mcg of gp120 (CHO) BIOCINE in MF59 Emulsion Versus the Emulsion Control: Three Injections at 0, 1, and 6 Months

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 14
Not applicableStudy completedNCT05116748
What this trial is testing

COVID19 Vaccine in SOT Adult Recipients

Who this might be right for
COVID-19Vaccine Adverse ReactionVaccine Response Impaired+4 more
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 364
Early research (Phase 1)Study completedNCT00254826
What this trial is testing

Yellow Fever Virus Vaccine and Immune Globulin Study

Who this might be right for
Viremia
Emory University 80
Next Page